Donepezil compared with non-drug care for Alzheimer’s
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This trial compares donepezil (a medicine for Alzheimer’s symptoms) against a non-drug treatment plan. It aims to see which approach helps people with Alzheimer’s who still have measurable thinking ability and specific Alzheimer’s test results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of Alzheimer’s disease based on specific guidelines.
- You are age 50 or older.
- Your thinking test (MMSE) is at least 10 at the start of the study.
- Your spinal fluid tests (Aβ42 and/or Aβ40/Aβ42 ratio, and tau) are abnormal in a way linked to Alzheimer’s.
- You speak French as your native language, and you have a family caregiver at home to help with the plan.
- You should not be on certain heart-rhythm–affecting medicines or strong medication interactions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two different ways of prescribing cholinesterase inhibitors (common Alzheimer's medications) to see which works better over time. If you or your loved one has mild to moderate Alzheimer's and has never taken these medications, this trial may help find the best treatment approach.
This study looks at how well people with Alzheimer’s disease (AD) or mild cognitive impairment (MCI) perform on standardized memory/brain tests. It may help researchers understand changes over time, and whether certain types of brain signals or test results track with the condition.
This trial tests if a daily pill (donepezil) helps women with anorexia nervosa, specifically the restrictive type (where you limit food intake). The study aims to see if the drug improves weight or eating behaviors compared to a placebo (no active drug).
This study tests whether a medication called donepezil, usually used for memory problems, can help people with anorexia nervosa break repetitive habits around food and eating. If it works, it might make it easier to change eating behaviors.
This study tests whether Huperzine A controlled-release tablets can help improve memory and thinking in people with mild-to-moderate Alzheimer's disease. You'll take the tablets or a placebo to see if it slows down dementia symptoms.
This trial tests a new drug, NBI-1117567, for people with mild to moderate Alzheimer's disease who are already taking a standard Alzheimer's medication. The goal is to see if the new drug can help improve symptoms.
Hear when a new Alzheimer Disease, Early Onset trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.